Published in J Urol on April 01, 2003
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
CLINICAL PRACTICE. Urinary Tract Infections in Older Men. N Engl J Med (2016) 2.76
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A (2009) 2.33
Delayed primary closure of bladder exstrophy: immediate postoperative management leading to successful outcomes. Urology (2011) 2.26
Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol (2011) 2.08
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol (2006) 1.68
Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol (2003) 1.66
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain. PLoS One (2013) 1.53
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Molecular effects of genistein on male urethral development. J Urol (2011) 1.51
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators. J Urol (2010) 1.46
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol (2015) 1.45
Data mining derived treatment algorithms from the electronic medical record improve theoretical empirical therapy for outpatient urinary tract infections. J Urol (2011) 1.44
Host-pathogen interactions mediating pain of urinary tract infection. J Infect Dis (2010) 1.44
Prostatitis/chronic pelvic pain syndrome. Annu Rev Med (2006) 1.44
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol (2008) 1.39
Urinary tract infections in women. Med Clin North Am (2011) 1.34
Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol (2006) 1.32
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy. Urol Clin North Am (2007) 1.24
Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun (2009) 1.24
Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21
Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology (2006) 1.20
Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. J Urol (2013) 1.17
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun (2006) 1.15
Angiosarcoma of bladder: long-term survival after multimodal therapy. Urology (2007) 1.12
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10
Role of mast cells in male chronic pelvic pain. J Urol (2012) 1.07
Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol (2002) 1.06
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology (2007) 1.06
Epithelial differentiation promotes the adherence of type 1-piliated Escherichia coli to human vaginal cells. J Infect Dis (2002) 1.06
CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol (2012) 0.96
A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis (2009) 0.96
Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents (2008) 0.95
Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol (2004) 0.95
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol (2005) 0.93
Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol (2009) 0.93
Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am (2003) 0.92
Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect (2008) 0.90
O-antigen modulates infection-induced pain states. PLoS One (2012) 0.89
Acute and chronic prostatitis. Med Clin North Am (2004) 0.86
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep (2008) 0.84
Role of bacteria in chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep (2005) 0.84
The expanding role of fluoroquinolones. Dis Mon (2003) 0.83
Epidemiologic insights into pediatric kidney stone disease. Urol Res (2010) 0.82
Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid (2015) 0.81
Is it time to change the training of urology residents in the United States? J Urol (2005) 0.81
Long-term results of the bulbourethral sling procedure. J Urol (2005) 0.80
Genitourinary pain syndromes, prostatitis, and lower urinary tract symptoms. Urol Clin North Am (2009) 0.79
Evaluation of the cytokines in genital secretions of patients with chronic prostatitis. J Urol (2005) 0.79
The role of cytokines in prostatitis. World J Urol (2003) 0.79
Durability of flexible cystoscopes in the outpatient setting. Urology (2013) 0.79
Urinary tract infections in adults. ScientificWorldJournal (2004) 0.78
Significant clinical practice cost savings through downsizing office supply inventory and just in time ordering. J Urol (2006) 0.78
The impact of collateral damage on urological care. J Urol (2012) 0.77
Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Urol (2003) 0.77
Management of bacterial urinary tract infections in adult patients with diabetes mellitus. J Urol (2003) 0.77
Levofloxacin: an updated review of its use in the treatment of bacterial infections. J Urol (2003) 0.75
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy. BJU Int (2013) 0.75
Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. J Urol (2003) 0.75
Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection--usp, iha, and iroN(E. coli). J Urol (2003) 0.75
Non-secretor status is associated with female acute uncomplicated pyelonephritis. J Urol (2003) 0.75
Physical therapist management of fluoroquinolone-induced Achilles tendinopathy. J Urol (2003) 0.75
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. J Urol (2003) 0.75
Renal imaging in pyelonephritis. J Urol (2005) 0.75
Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Urol (2005) 0.75
Utility of blood cultures in febrile children with UTI. J Urol (2003) 0.75
The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. J Urol (2003) 0.75
Evaluation of the DipStreak, a new device with an original streaking mechanism for detection, counting, and presumptive identification of urinary tract pathogens. J Urol (2003) 0.75
Prostatectomy incontinence. J Urol (2002) 0.75
Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urology. J Urol (2005) 0.75
Cytologic evaluation of urine is important in evaluation of chronic prostatitis. J Urol (2003) 0.75
Urinary tract infection as a possible marker for teenage sex. J Urol (2003) 0.75
Cranberries for preventing urinary tract infections. J Urol (2005) 0.75
Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. J Urol (2003) 0.75
Editorial: Emerging concepts in the management of prostatitis/chronic pelvic pain syndrome. J Urol (2003) 0.75
The economic impact of chronic prostatitis. J Urol (2005) 0.75
Asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors and elevated number in neutrophils. J Urol (2003) 0.75
Cranberry juice and urinary tract infection. J Urol (2005) 0.75
Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. J Urol (2003) 0.75
Types of urethral catheters for management of short-term voiding problems in hospitalised adults. J Urol (2005) 0.75
Antibiotic treatment for five days is effective in children with acute cystitis. J Urol (2003) 0.75
National Institutes of Health Chronic Prostatitis Symptom Index for Japanese men. J Urol (2003) 0.75
Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J Urol (2003) 0.75
Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. J Urol (2003) 0.75